89Bio Inc
(ETNB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ETNB | AAPG | MESO | ||
| Company | 89Bio Inc | Ascentage Pharma Group Intl ADR | Mesoblast Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.83 | 23.81 | 17.51 | ||
| High | 14.87 | 24.01 | 18.16 | ||
| Low | 14.82 | 23.81 | 17.51 | ||
| Latest | 14.84 | 24.01 | 18.04 | ||
| Change | unch | +0.40 | +1.26 | ||
| % Change | unch | +1.69% | +7.51% | ||
| Volume | 55,645,300 | 1,922 | 241,597 | ||
| 20-Day Average Volume | 6,202,360 | 3,016 | 205,598 | ||
| Previous Close | 14.84 | 23.61 | 16.78 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.81 | 25.55 | 17.60 | ||
| 20-Day Raw Stochastic | 54.05% | 15.79% | 65.96% | ||
| 20-Day Relative Strength | 74.10 | 39.20 | 51.51 | ||
| Weighted Alpha | +10.94 | -8.68 | -0.52 | ||
| Today's Opinion | 100% Buy | 100% Sell | 56% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 10/22/25 | +2.91% since 02/03/26 | +4.09% since 02/03/26 | ||
| Low | 14.78 on 10/24/25 | 23.50 on 02/05/26 | 15.55 on 02/06/26 | ||
| High | 14.87 on 10/29/25 | 24.53 on 02/06/26 | 18.16 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +0.95% since 09/29/25 | -16.57% since 01/09/26 | -13.88% since 01/09/26 | ||
| Low | 14.67 on 09/30/25 | 23.17 on 02/02/26 | 15.55 on 02/06/26 | ||
| High | 14.93 on 10/02/25 | 28.49 on 01/12/26 | 19.35 on 01/12/26 | ||
| 3-Month | |||||
| %Chg | +60.95% since 07/29/25 | -25.90% since 11/10/25 | +18.67% since 11/10/25 | ||
| Low | 7.84 on 09/15/25 | 23.17 on 02/02/26 | 14.32 on 11/20/25 | ||
| High | 15.06 on 09/18/25 | 34.50 on 11/14/25 | 21.50 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +96.56% since 04/29/25 | -42.77% since 08/08/25 | +20.09% since 08/08/25 | ||
| Low | 7.37 on 05/15/25 | 23.17 on 02/02/26 | 12.66 on 09/03/25 | ||
| High | 15.06 on 09/18/25 | 48.45 on 08/22/25 | 21.50 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,200,891 | 2,203,522 | 2,165,123 | ||
| Shares Outstanding, K | 148,308 | 93,330 | 129,030 | ||
| Annual Sales | 0 | 134,350,000 | 17,200,000 | ||
| Annual Net Income | -367,080,000 | -55,540,000 | -102,140,000 | ||
| Last Quarter Sales | 0 | N/A | 1,930,000 | ||
| Last Quarter Net Income | -111,500,000 | N/A | -21,920,000 | ||
| 60-Month Beta | 1.27 | N/A | 2.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 08/07/25 | N/A | N/A on 09/06/19 | ||
| Latest Earnings Date | 11/06/25 | 03/26/26 | 09/03/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||